OPCH Strangle Strategy
OPCH (Option Care Health, Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH (Option Care Health, Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $3.11B, a trailing P/E of 15.03, a beta of 0.68 versus the broader market, a 52-week range of 18.01-36.8, average daily share volume of 2.5M, a public-listing history dating back to 1996, approximately 8K full-time employees. These structural characteristics shape how OPCH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.68 indicates OPCH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on OPCH?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current OPCH snapshot
As of May 15, 2026, spot at $19.51, ATM IV 37.80%, IV rank 6.32%, expected move 10.84%. The strangle on OPCH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this strangle structure on OPCH specifically: OPCH IV at 37.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a OPCH strangle, with a market-implied 1-standard-deviation move of approximately 10.84% (roughly $2.11 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OPCH expiries trade a higher absolute premium for lower per-day decay. Position sizing on OPCH should anchor to the underlying notional of $19.51 per share and to the trader's directional view on OPCH stock.
OPCH strangle setup
The OPCH strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OPCH near $19.51, the first option leg uses a $20.49 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OPCH chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OPCH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $20.49 | N/A |
| Buy 1 | Put | $18.53 | N/A |
OPCH strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
OPCH strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on OPCH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on OPCH
Strangles on OPCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OPCH chain.
OPCH thesis for this strangle
The market-implied 1-standard-deviation range for OPCH extends from approximately $17.40 on the downside to $21.62 on the upside. A OPCH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current OPCH IV rank near 6.32% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OPCH at 37.80%. As a Healthcare name, OPCH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OPCH-specific events.
OPCH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OPCH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OPCH alongside the broader basket even when OPCH-specific fundamentals are unchanged. Always rebuild the position from current OPCH chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on OPCH?
- A strangle on OPCH is the strangle strategy applied to OPCH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With OPCH stock trading near $19.51, the strikes shown on this page are snapped to the nearest listed OPCH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OPCH strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the OPCH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OPCH strangle?
- The breakeven for the OPCH strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OPCH market-implied 1-standard-deviation expected move is approximately 10.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on OPCH?
- Strangles on OPCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OPCH chain.
- How does current OPCH implied volatility affect this strangle?
- OPCH ATM IV is at 37.80% with IV rank near 6.32%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.